12 September 2024 in Trends in Biotechnology
We recently proposed a two-stage Power-to-Protein technology to produce microbial protein from renewable electric power and CO2. Two stages were operated in series: Clostridium ljungdahlii in Stage A to reduce CO2 with H2 into acetate, and Saccharomyces cerevisiae in Stage B to utilize O2 and produce microbial protein from acetate. Renewable energy can be used to power water electrolysis to produce H2 and O2. A drawback of Stage A was the need for continuous vitamin supplementation. In this study, by using the more robust thermophilic acetogen Thermoanaerobacter kivui instead of C. ljungdahlii, vitamin supplementation was no longer needed. Additionally, S. cerevisiae produced folate when grown with acetate as a sole carbon source, achieving a total folate concentration of 6.7 mg per 100 g biomass with an average biomass concentration of 3 g l-1. The developed Power-to-Vitamin system enables folate production from renewable power and CO2 with zero or negative net-carbon emissions.
1 March 2021 in ChemBioChem
The active vitamin D metabolites 25‐OH−D and 1α,25‐(OH)2−D play an essential role in controlling several cellular processes in the human body and are potentially effective in the treatment of several diseases, such as autoimmune diseases, cardiovascular diseases and cancer. The microbial synthesis of vitamin D2 (VD2) and vitamin D3 (VD3) metabolites has emerged as a suitable alternative to established complex chemical syntheses. In this study, a novel strain, Kutzneria albida, with the ability to form 25‐OH−D2 and 25‐OH−D3 was identified. To further improve the conversion of the poorly soluble substrates, several solubilizers were tested. 100‐fold higher product concentrations of 25‐OH−D3 and tenfold higher concentrations of 25‐OH−D2 after addition of 5 % (w/v) 2‐hydroxypropyl β‐cyclodextrin (2‐HPβCD) were reached. Besides the single‐hydroxylation products, the human double‐hydroxylation products 1,25‐(OH)2−D2 and 1,25‐(OH)2−D3 and various other potential single‐ and double‐hydroxylation products were detected. Thus, K. albida represents a promising strain for the biotechnological production of VD2 and VD3 metabolites.
11 August 2026 in Proceedings of the National Academy of Sciences
We assessed the economic viability of a two-stage system for producing folate- and protein-enriched yeast biomass using acetate derived from CO 2 and renewable electric power at a 1,750 m 3 scale. In a Power-to-vitamin system producing a biomass product for partial daily protein intakes, heating for nucleic acids removal is unnecessary. Under these conditions, a CO 2 input of 31.3 kt CO2 y −1 yields 12.9 kt product y −1 containing 813 kg folate y −1 and 5.6 kt protein y −1 (43% of yeast biomass). This production volume meets the full recommended daily allowance (RDA) for folate and 5% of RDA for protein of 5.6 million people when each person consumes 6 g of dried yeast product daily. At a selling price of $20 kg product −1 , the system’s payback period is 5 y. In a baseline scenario, the minimum selling price (MSP) is $8.41 kg product −1 , largely driven by electric-power pricing and energy demand of water electrolysis. An ideal scenario simulation reduced the MSP to $4.53 kg product −1 , combining: 1) lower water purity requirements for electrolysis; 2) higher yeast production rate; 3) lower electric-power pricing; and 4) no CO 2 procurement costs and lower ammonium costs. In a Power-to-protein system with a biomass product designed to meet full daily protein needs, heat treatment is necessary, which increases the MSP to $14.24 kg product −1 . At a selling price of $20 kg product −1 , the payback period is 7 y, exhibiting lower overall profitability than the Power-to-vitamin system. Both modeled systems are economically viable at selling prices competitive with plant-, whey-, algae-, and yeast-derived protein products.